{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:45Z","timestamp":1787020845533,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sumitomo Pharma Co., Ltd.","award":["Not applicable."],"award-info":[{"award-number":["Not applicable."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Understanding the treatment needs of patients with dementia with Lewy bodies (DLB) is essential to develop treatment strategies. We examined the treatment needs of patients with DLB and their caregivers and the extent to which the attending physicians understand these treatment needs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a cross-sectional, observational study conducted using questionnaires for patients, caregivers, and physicians. The study participants included patients, their caregivers, and their attending physicians who were experts in DLB. Fifty-two symptoms that are frequent and clinically important in DLB were pre-selected and classified into seven symptom domains. Treatment needs of patients and caregivers were defined as \u201csymptom that causes them most distress,\u201d and the frequency of each answer was tabulated. To assess the physician\u2019s understanding of the treatment needs of patients and caregivers, patient\u2013physician and caregiver\u2013physician concordance rates for each answer regarding treatment needs were calculated according to symptom domains.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 263 pairs of patients\u2013caregivers and 38 physicians were surveyed. The mean age of patients was 79.3 years, and their mean total score on the Mini-Mental State Examination was 20.9. Thirty-five and 38 symptoms were selected as symptoms causing patients and caregivers most distress, respectively. Memory impairment was most frequently selected for the treatment needs of patients, followed by constipation and bradykinesia. Memory impairment was also most frequently selected by caregivers, followed by visual hallucinations. For the symptom domain that causes patients or caregivers most distress, only about half of the patient\u2013physician pairs (46.9%) and caregiver\u2013physician pairs (50.8%) were matched. Logistic regression analysis identified that concordance rates for treatment needs between patient\u2013physician and caregiver\u2013physician were lower when autonomic dysfunction and sleep-related disorders were selected as the symptom domains that cause most distress.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There was considerable variability in the treatment needs of patients with DLB and their caregivers. Attending physicians had difficulty understanding the top\u00a0treatment needs of their patients and caregivers, despite their expertise in DLB, because of various clinical manifestations. Attending physicians should pay more attention to autonomic dysfunction and sleep-related disorders in the treatment of DLB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>UMIN Clinical Trials Registry, UMIN000041844. Registered on 23 September 2020<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-022-01130-4","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T02:02:52Z","timestamp":1671069772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment needs of dementia with Lewy bodies according to patients, caregivers, and physicians: a cross-sectional, observational, questionnaire-based study in Japan"],"prefix":"10.1186","volume":"14","author":[{"given":"Mamoru","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Manabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuhiro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Toya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"1130_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","volume":"3","author":"I McKeith","year":"2004","unstructured":"McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. Dementia with Lewy bodies. Lancet Neurol. 2004;3:19\u201328.","journal-title":"Lancet Neurol"},{"key":"1130_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/S0033291713000494","volume":"44","author":"SA Vann Jones","year":"2014","unstructured":"Vann Jones SA, O\u2019Brien JT. The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychol Med. 2014;44:673\u201383.","journal-title":"Psychol Med"},{"key":"1130_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-018-0350-6","volume":"10","author":"JPM Kane","year":"2018","unstructured":"Kane JPM, Surendranathan A, Bentley A, Barker SAH, Taylor J-P, Thomas AJ, et al. Clinical prevalence of Lewy body dementia. Alzheimers Res Ther. 2018;10:19.","journal-title":"Alzheimers Res Ther"},{"key":"1130_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89:88\u2013100.","journal-title":"Neurology."},{"key":"1130_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/psyg.12005","volume":"13","author":"H Fujishiro","year":"2013","unstructured":"Fujishiro H, Iseki E, Nakamura S, Kasanuki K, Chiba Y, Ota K, et al. Dementia with Lewy bodies: early diagnostic challenges. Psychogeriatr. 2013;13:128\u201338.","journal-title":"Psychogeriatr."},{"key":"1130_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/jnnp.2009.186239","volume":"81","author":"U Ehrt","year":"2010","unstructured":"Ehrt U, Broich K, Larsen J, Ballard C, Aarsland D. Use of drugs with anticholinergic effect and impact on cognition in Parkinson\u2019s disease: a cohort study. J Neurol Neurosurg Psychiatry. 2010;81:160\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1130_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"S Gray","year":"2015","unstructured":"Gray S, Anderson M, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175:401\u20137.","journal-title":"JAMA Intern Med"},{"key":"1130_CR8","doi-asserted-by":"publisher","first-page":"III28","DOI":"10.1007\/PL00007823","volume":"248 Suppl 3","author":"S Kuzuhara","year":"2001","unstructured":"Kuzuhara S. Drug-induced psychotic symptoms in Parkinson\u2019s disease. Problems, management and dilemma. J Neurol. 2001;248 Suppl 3:III28\u201331.","journal-title":"J Neurol"},{"key":"1130_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3988\/jcn.2012.8.1.15","volume":"8","author":"HW Shin","year":"2012","unstructured":"Shin HW, Chung SJ. Drug-induced parkinsonism. J Clin Neurol. 2012;8:15\u201321.","journal-title":"J Clin Neurol"},{"key":"1130_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40266-018-00636-7","volume":"36","author":"L Hershey","year":"2019","unstructured":"Hershey L, Coleman-Jackson R. Pharmacological management of dementia with Lewy bodies. Drugs Aging. 2019;36:309\u201319.","journal-title":"Drugs Aging"},{"key":"1130_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(19)30153-X","volume":"19","author":"J Taylor","year":"2020","unstructured":"Taylor J, McKeith I, Burn J, Boeve B, Weintraub D, Bamford C, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19:157\u201369.","journal-title":"Lancet Neurol"},{"key":"1130_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jalz.2007.04.383","volume":"3","author":"LB Frank","year":"2007","unstructured":"Frank LB. Commentary on \u201cHealth economics and the value of therapy in Alzheimer\u2019s disease.\u201d Report from the Alzheimer\u2019s Association Research Roundtable on patient-reported outcomes and dementia research. Alzheimers Dement. 2007;3:162\u20135.","journal-title":"Alzheimers Dement"},{"key":"1130_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/21678421.2020.1760889","volume":"21","author":"KT Brizzi","year":"2020","unstructured":"Brizzi KT, Bridges JFP, Yersak J, Balas C, Thakur N, Galvin M, et al. Understanding the needs of people with ALS: a national survey of patients and caregivers. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:355\u201363.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"1130_CR14","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/j.archger.2008.10.001","volume":"49","author":"M Ricci","year":"2009","unstructured":"Ricci M, Guidoni S, Sepe-Monti M, Bomboi G, Antonini G, Blundo C, et al. Clinical findings, functional abilities and caregiver distress in the early stage of dementia with Lewy bodies (DLB) and Alzheimer\u2019s disease (AD). Arch Gerontol Geriatr. 2009;49:e101\u20134.","journal-title":"Arch Gerontol Geriatr"},{"key":"1130_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/gps.3799","volume":"28","author":"D Lee","year":"2013","unstructured":"Lee D, McKeith I, Mosimann U, Ghosh-Nodyal A, Thomas A. Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms. Int J Geriatr Psychiatry. 2013;28:135\u201341.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1130_CR16","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/gps.4433","volume":"31","author":"E Svendsboe","year":"2016","unstructured":"Svendsboe E, Terum T, Testad I, Aarsland D, Ulstein I, Corbett A, et al. Caregiver burden in family carers of people with dementia with Lewy bodies and Alzheimer\u2019s disease. Int J Geriatr Psychiatry. 2016;31:1075\u201383.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1130_CR17","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/geront\/gnq055","volume":"51","author":"AN Leggett","year":"2011","unstructured":"Leggett AN, Zarit S, Taylor A, Galvin JE. Stress and burden among caregivers of patients with Lewy body dementia. Gerontologist. 2011;51:76\u201385.","journal-title":"Gerontologist."},{"key":"1130_CR18","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/psyg.12740","volume":"21","author":"H Sato","year":"2021","unstructured":"Sato H, Nakaaki S, Sato J, Shikimoto R, Furukawa TA, Mimura M, et al. Caregiver self-efficacy and associated factors among caregivers of patients with dementia with Lewy bodies and caregivers of patients with Alzheimer\u2019s disease. Psychogeriatrics. 2021;21:783\u201394.","journal-title":"Psychogeriatrics."},{"key":"1130_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/WAD.0000000000000459","volume":"35","author":"M Armstrong","year":"2021","unstructured":"Armstrong M, Gamez N, Alliance S, Majid T, Taylor AS, Kurasz AM, et al. Clinical care and unmet needs of individuals with dementia with Lewy bodies and caregivers: an interview study. Alzheimer Dis Assoc Disord. 2021;35:327\u201334.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1130_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1017\/S1041610215001362","volume":"28","author":"A Killen","year":"2016","unstructured":"Killen A, Flynn D, Brun A, O'Brien N, O'Brien J, Thomas AJ, et al. Support and information needs following a diagnosis of dementia with Lewy bodies. Int Psychogeriatr. 2016;28:495\u2013501.","journal-title":"Int Psychogeriatr"},{"key":"1130_CR21","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"IG McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113\u201324.","journal-title":"Neurology."},{"key":"1130_CR22","unstructured":"Dementia with Lewy bodies Research Groups in Japan. http:\/\/www.d-lewy.com\/index.html. Accessed 6 May 2022. [in Japanese]."},{"key":"1130_CR23","unstructured":"Dementia with Lewy bodies Support Network in Japan. http:\/\/dlbsn.org. Accessed 6 May 2022. [in Japanese]."},{"key":"1130_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"M Folstein","year":"1975","unstructured":"Folstein M, Folstein S, McHugh P. \u201cMini-Mental State\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189\u201398.","journal-title":"J Psychiatr Res"},{"key":"1130_CR25","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129\u201370.","journal-title":"Mov Disord"},{"key":"1130_CR26","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","volume":"48","author":"JL Cummings","year":"1997","unstructured":"Cummings JL. The neuropsychiatric inventory: assessing psychopathology in dementia patients. Neurology. 1997;48:S10\u20136.","journal-title":"Neurology."},{"key":"1130_CR27","first-page":"175","volume":"66","author":"M Hashimoto","year":"2014","unstructured":"Hashimoto M, Manabe Y, Mori E, Hirono N, Kosaka K, Ikeda M. Content validity inter-rater reliability of the Cognitive Fluctuation Inventory. Brain Nerve. 2014;66:175\u201383 [in Japanese].","journal-title":"Brain Nerve"},{"key":"1130_CR28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/geront\/20.6.649","volume":"20","author":"SH Zarit","year":"1980","unstructured":"Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980;20:649\u201355.","journal-title":"Gerontologist."},{"key":"1130_CR29","volume-title":"Manual of the SF-8 Japanese version","author":"S Fukuhara","year":"2004","unstructured":"Fukuhara S, Suzukamo Y. Manual of the SF-8 Japanese version. Kyoto: Institute for Health Outcomes and Process Evaluation Research; 2004."},{"key":"1130_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"J Landis","year":"1977","unstructured":"Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159\u201374.","journal-title":"Biometrics."},{"key":"1130_CR31","unstructured":"Department of Health and Social Care. Living well with dementia: a national dementia strategy. https:\/\/www.gov.uk\/government\/news\/living-well-with-dementia-a-national-dementia-strategy. Accessed 28 May 2022."},{"key":"1130_CR32","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/archneur.55.12.1547","volume":"55","author":"T Shimomura","year":"1998","unstructured":"Shimomura T, Mori E, Yamashita H, Hirono N, Hashimoto M, Tanimukai S, et al. Cognitive loss in dementia with Lewy bodies and Alzheimer disease. Arch Neurol. 1998;55:1547\u201352.","journal-title":"Arch Neurol"},{"key":"1130_CR33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/gps.550","volume":"17","author":"T Ala","year":"2002","unstructured":"Ala T, Hughes L, Kyrouac G, Ghobrial M, Elble R. The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer\u2019s disease. Int J Geriatr Psychiatry. 2002;17:503\u20139.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1130_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000447586","volume":"42","author":"E Mori","year":"2016","unstructured":"Mori E, Ikeda M, Nakagawa M, Miyagishi H, Kosaka K. Pretreatment cognitive profile likely to benefit from donepezil treatment in dementia with Lewy bodies: pooled analyses of two randomized controlled trials. Dement Geriatr Cogn Disord. 2016;42:58\u201368.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1130_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000333072","volume":"32","author":"E Auning","year":"2011","unstructured":"Auning E, Rongve A, Fladby T, Booij J, Hortob\u00e1gyi T, Siepel FJ, et al. Early and presenting symptoms of dementia with Lewy bodies. Dement Geriatr Cogn Disord. 2011;32:202\u20138.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1130_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000339363","volume":"33","author":"Y Chiba","year":"2012","unstructured":"Chiba Y, Fujishiro H, Iseki E, Ota K, Kasanuki K, Hirayasu Y, et al. Retrospective survey of prodromal symptoms in dementia with Lewy bodies: comparison with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2012;33:273\u201381.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1130_CR37","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1517\/14656566.2015.997211","volume":"16","author":"M Rossi","year":"2015","unstructured":"Rossi M, Merello M, Perez-Lloret S. Management of constipation in Parkinson\u2019s disease. Expert Opin Pharmacother. 2015;16:547\u201357.","journal-title":"Expert Opin Pharmacother"},{"key":"1130_CR38","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/mds.10455","volume":"18","author":"DJ Burn","year":"2003","unstructured":"Burn DJ, Rowan EN, Minett T, Sanders J, Myint P, Richardson J, et al. Extrapyramidal features in Parkinson\u2019s disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord. 2003;18:884\u20139.","journal-title":"Mov Disord"},{"key":"1130_CR39","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/01.JGP.0000216177.08010.f4","volume":"14","author":"I McKeith","year":"2006","unstructured":"McKeith I, Rowan E, Askew K, Naidu A, Allan L, Barnett N, et al. More severe functional impairment in dementia with Lewy bodies than Alzheimer disease in related to extrapyramidal motor dysfunction. Am J Geriatr Psychiatry. 2006;14:582\u20138.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1130_CR40","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1017\/S1041610297004523","volume":"9","author":"C Ballard","year":"1997","unstructured":"Ballard C, McKeith I, Harrison R, O'Brien J, Thompson P, Lowery K, et al. A detailed phenomenological comparison of complex visual hallucinations in dementia with Lewy bodies and Alzheimer\u2019s disease. Int Psychogeriatr. 1997;9:381\u20138.","journal-title":"Int Psychogeriatr"}],"updated-by":[{"DOI":"10.1186\/s13195-022-01155-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000}}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01130-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-01130-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01130-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T21:06:49Z","timestamp":1673212009000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-01130-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-01130-4","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"23 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13195-022-01155-9","URL":"https:\/\/doi.org\/10.1186\/s13195-022-01155-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"After approval by the Observational Study Ethics Committee of Osaka University Hospital (IRB No., 20171-4, November 11, 2020), this study was conducted in compliance with the ethical principles of the Declaration of Helsinki (revised in 2013), the Ethical Guidelines for Medical and Health Research Involving Human Subjects (partially revised in 2017), and the research protocol. This study was registered at UMIN Clinical Trials Registry under the identifier number UMIN000041844. Written informed consent was obtained from all patients and their caregivers. Physicians consented to participate in this study via the web.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MH has received travel expenses from Sumitomo Pharma Co., Ltd. YM has received research funding and travel expenses from Sumitomo Pharma Co., Ltd. ST is an employee of Sumitomo Pharma Co., Ltd. MI has received research funding from Sumitomo Pharma Co., Ltd. TY has no competing interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}